Application of Caenorhabditis elegans (nematode) and Danio rerio embryo (zebrafish) as model systems to screen for developmental and reproductive toxicity of Piperazine compounds

• Published in: Toxicology in vitro 2017-10, Vol.44, p.11-16
• Main Authors: Racz, Peter I., Wildwater, Marjolein, Rooseboom, Martijn, Kerkhof, Engelien, Pieters, Raymond, Yebra-Pimentel, Elena Santidrian, Dirks, Ron P., Spaink, Herman P., Smulders, Chantal, Whale, Graham F.
• Format: Article
• Language: English
• Subjects: Analogs; Animal welfare; Animals; Assaying; Biotransformation; Caenorhabditis elegans; Caenorhabditis elegans - drug effects; Caenorhabditis elegans - embryology; Cell culture; Chemicals; Danio rerio; Data processing; Development; Ecological risk assessment; Embryo, Nonmammalian; Embryonic Development - drug effects; Embryos; Environmental assessment; Environmental hazards; Hazard assessment; Health hazards; Hypothalamus; Life cycle engineering; Life cycles; Models, Animal; Mortality; Nematode; Nematodes; Organic chemistry; Piperazine; Piperazines - toxicity; Pituitary; Predictions; Reproduction; Reproduction - drug effects; Screening; Toxicity; Toxicology; Zebrafish; Zebrafish - embryology
• ISSN: 0887-2333; 1879-3177
• DOI: 10.1016/j.tiv.2017.06.002

To enable selection of novel chemicals for new processes, there is a recognized need for alternative toxicity screening assays to assess potential risks to man and the environment. For human health hazard assessment these screening assays need to be translational to humans, have high throughput capability, and from an animal welfare perspective be harmonized with the principles of the 3Rs (Reduction, Refinement, Replacement). In the area of toxicology a number of cell culture systems are available but while these have some predictive value, they are not ideally suited for the prediction of developmental and reproductive toxicology (DART). This is because they often lack biotransformation capacity, multicellular or multi- organ complexity, for example, the hypothalamus pituitary gonad (HPG) axis and the complete life cycle of whole organisms. To try to overcome some of these limitations in this study, we have used Caenorhabditis elegans (nematode) and Danio rerio embryos (zebrafish) as alternative assays for DART hazard assessment of some candidate chemicals being considered for a new commercial application. Nematodes exposed to Piperazine and one of the analogs tested showed a slight delay in development compared to untreated animals but only at high concentrations and with Piperazine as the most sensitive compound. Total brood size of the nematodes was also reduced primarily by Piperazine and one of the analogs. In zebrafish Piperazine and analogs showed developmental delays. Malformations and mortality in individual fish were also scored. Significant malformations were most sensitively identified with Piperazine, significant mortality was only observed in Piperazine and only at the higest dose. Thus, Piperazine seemed the most toxic compound for both nematodes and zebrafish. The results of the nematode and zebrafish studies were in alignment with data obtained from conventional mammalian toxicity studies indicating that these have potential as developmental toxicity screening systems. The results of these studies also provided reassurance that none of the Piperazines tested are likely to have any significant developmental and/or reproductive toxicity issues to humans when used in their commercial applications. •Nematodes and zebrafish embryos can be used to prioritize Piperazine analogs for DART.•Piperazine shows mild DART effects in mammals like in the 3R systems from this study.•Piperazine analogs are unlikely to have strong DART issues based on data f